ClinicalTrials.Veeva

Menu

Evaluation of the Implementation of the Hemispheric Dominance During Development (HEMISPHERENOR)

C

Centre Hospitalier Universitaire, Amiens

Status

Active, not recruiting

Conditions

Neuroimaging

Treatments

Device: Near Infra Red Spectroscopy (NIRS)
Device: Electroencephalogram (EEG)
Device: magnetic resonance imaging (MRI)

Study type

Observational

Funder types

Other

Identifiers

NCT02826733
PI08-DR-WALLOIS

Details and patient eligibility

About

Many cognitive functions in human are based on asymmetric brain networks. For most adults, language is processed largely by the left hemisphere while other auditory treatments, such as voice recognition are rather based on the right hemisphere. Many studies helped to highlight the presence of anatomical and functional asymmetries both in the first months of life. What are the causes of these imbalances? How do they develop? Are they necessary for operation or for effective learning?

The investigators would like in this work, in collaboration with applied mathematics team of Compiègne and INSERM team, to determine from which period the development of hemispheric dominance is set up for recognition of language and in which brain structure it occurs in preterm infants whose sound environment is usually very different from that of the fetus. The impact of this environment on brain development of infants and their early learning will be assessed.

Enrollment

120 estimated patients

Sex

All

Ages

Under 10 weeks old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • preterm gestational age over 26 weeks of gestation + 6 days and less than 42 weeks.
  • normal group of children : A child meets the age criteria and without ductus arteriosus persistence ultrasound or detectable neurological disorders after clinical, neurophysiological and radiological (ETF , Scanner, MRI).
  • Group of children meet the age criteria and with cerebral neurological pathology detectable after clinical, neurophysiological and radiological (ETF , Scanner, MRI).

Exclusion criteria

  • severe congenital malformation
  • Any refusal of a parent .
  • Children with severe impairment of the general condition and vital functions
  • Children with dermatitis of the face or scalp
  • Children treated with ventilation High Frequency (HFO )
  • Presence of intravenous access on the scalp ( preventing the realization of the ETF , EEG or NIRS .

Trial design

120 participants in 2 patient groups

Normal
Description:
Every child meet the age criteria and without ductus arteriosus persistence ultrasound or detectable neurological disorders after clinical, neurophysiological and radiological (ETF , Scanner, MRI). EEG NIRS MRI
Treatment:
Device: Near Infra Red Spectroscopy (NIRS)
Device: magnetic resonance imaging (MRI)
Device: Electroencephalogram (EEG)
cerebral neurological disease
Description:
Group of children meeting the criteria of age and having a detectable neurological disease after clinical, neurophysiological and radiological (ETF , Scanner, MRI) The children present either convulsions or a cerebrovascular accident or a neurological pain . Each condition being verified by a pathological electroencephalogram . EEG NIRS MRI
Treatment:
Device: Near Infra Red Spectroscopy (NIRS)
Device: magnetic resonance imaging (MRI)
Device: Electroencephalogram (EEG)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems